SNYNasdaq · Pharmaceutical Preparations

Sanofi

Alert me on SNY

Insider buys, 6 months

Congress trades, 6 months

Signals, 6 months

Six months

After each filing

Jul 21 Buy Sen. Alan Armstrong Senate

1 week

+2.4%S&P −2.4%

1 month

+3.1%S&P +2.0%

3 months

−5.5%S&P +3.2%

6 months

Result in60 trading days

Oct 22, 2025 Sale Rep. Lisa McClain House

1 week

+2.9%S&P +1.2%

1 month

+0.2%S&P −1.9%

3 months

−4.4%S&P +3.4%

6 months

−7.3%S&P +7.1%

Sep 12, 2025 Buy Rep. Lisa McClain House

1 week

+0.8%S&P +1.2%

1 month

+5.6%S&P +0.5%

3 months

+4.4%S&P +3.4%

6 months

−5.5%S&P +2.1%

Aug 13, 2025 Buy Rep. Lisa McClain House

1 week

+3.2%S&P −1.5%

1 month

−4.9%S&P +2.5%

3 months

+5.9%S&P +6.3%

6 months

−6.2%S&P +6.3%

Aug 13, 2025 Sale Rep. Lisa McClain House

1 week

+3.2%S&P −1.5%

1 month

−4.9%S&P +2.5%

3 months

+5.9%S&P +6.3%

6 months

−6.2%S&P +6.3%

Every purchase and sale on this ticker reported by a member of Congress or an insider, measured from the close of the first trading day after it became public to the close 1 week, 1 month, 3 months and 6 months later, each beside the S&P over the same days.

Filings for SNY

8 held · newest 58 held · newest 2

Loading the filings.

See all 8 filings for SNY

Aeon news and offers by email

New sources, new features and offers like our founding price. A few times a month at most. Stop any time.

Government contracts, last 12 months

Awards of $10M and up, from USAspending · context, not a signal

No contracts of $10M or more in the last 12 months.

Lobbying

Last four quarters

$1.1MQ4 2025

$2.6MQ1 2026

$920KQ2 2026

$1.3MQ3 2026

Up 36 percent from Q2 2026. Reported by the company to the Senate each quarter.Original report ↗

Read from LDA.gov between Sep 23, 2026 and Oct 21, 2026. Senate Office of Public Records cannot vouch for the data or analyses derived from these data after the data have been retrieved from LDA.gov.